We are doubling down to become a fragrance and scenting powerhouse from $5 to $500,” says Coty CEO Sue Y. Nabi, as the company accelerates ultra-premium and scenting growth ahead of the Gucci licence ...

Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1—including drug-resistant ...

Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancerPreparing for initial ...

Q3 2025 Earnings Call November 13, 2025 5:00 PM ESTCompany ParticipantsGuilherme Souto - Investor Relations Officer & Director ...

Cybin Inc. ( CYBN) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST ...

Based on industry trends, consumer insights and market research, IRAEmpire has prepared its updated list of the Best Gold IRA Companies in the USA. NEW YORK CITY, NEW YORK / ACCESS Newswire / November ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved ...